Restasis and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Gliclazide (gliclazide). Common drug interactions include epilepsy among females and mental disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Gliclazide. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

28 people who take Restasis and Gliclazide together, and have interactions are studied.

Restasis and Gliclazide drug interactions.

What are the common drug interactions of Restasis and Gliclazide, by gender? *:

female:

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Staphylococcal infection (an infection with staphylococcus bacteria)
Acne (skin problems that cause pimples)
Alopecia (absence of hair from areas of the body)
Disability
Fall
Hepatic steatosis (fatty liver disease)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Tremor (trembling or shaking movements in one or more parts of your body)
Weight decreased

male:

Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Schizoaffective disorder (a mental disorder characterized by disordered thought)
Asthenia (weakness)
Death
Fall
Fatigue (feeling of tiredness)
Gait disturbance
Lung cancer metastatic (lung cancer spreads to other parts)
Nephrolithiasis (calculi in the kidneys)
Schizoaffective disorder depressive type (mental illness featuring schizophrenia and a mood disorder)

What are the common drug interactions of Restasis and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Staphylococcal infection (an infection with staphylococcus bacteria)

40-49:

Bladder pain
Decreased appetite
Hot flush (sudden feelings of heat)
Night sweats (sweating in night)
Weight decreased

50-59:

n/a

60+:

Asthenia (weakness)
Death
Cardiac flutter (abnormal heart rhythm)
Chest pain
Dysgeusia (disorder of the sense of taste)
Lip swelling
Lung disorder (lung disease)
Oedema (fluid collection in tissue)
Pleural effusion (water on the lungs)
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 20 people, 71.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 53.57%
Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 4 people, 14.29%
Rashes (redness): 3 people, 10.71%
Migraine (headache): 2 people, 7.14%
Drowsiness: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously